WHO ICTRP trial
A clinical gene therapy study with hematopoietic stem cells for the treatment of…
CTIS2023-510299-29-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-510299-29-00 |
|---|---|
| Public title | A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a malignant neoplasm of the central nervous system |
| Scientific title | - TEM-GBM_001 |
| Primary sponsor | Genenta Science S.p.A. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Italy |
| Conditions | Glioblastoma multiforme MedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864 MedDRA version: 20.0Level: PTClassification code: 10018337Term: Glioblastoma multiforme Class: 100000004864;Therapeutic… |
| Registration date | Jan 26, 2024 |
| Target size | 27 |
| Secondary IDs | NCT03866109;2018-001404-11 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: